Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,156
Views
3
CrossRef citations to date
0
Altmetric
research paper

Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma

Qinglin ZhangDepartment of Gastroenterology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, ChinaView further author information
,
Jiadong PanDepartment of Gastroenterology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, ChinaView further author information
,
Fangmei AnDepartment of Gastroenterology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, ChinaView further author information
,
He NieDepartment of Gastroenterology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, ChinaView further author information
&
Qiang ZhanDepartment of Gastroenterology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2618-5475View further author information
ORCID Icon
Pages 8147-8156 | Received 01 Jul 2021, Accepted 24 Sep 2021, Published online: 21 Oct 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
  • Geh D, Anstee QM, Reeves HL. NAFLD-Associated HCC: progress and opportunities. J Hepatocell Carcinoma. 2021;8:223–239.
  • Perisetti A, Goyal H, Yendala R, et al. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: current insights and advancements. World J Gastroenterol. 2021;27(24):3466–3482.
  • Shimoda Y, Ubukata Y, Handa T, et al. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma. BMC Cancer. 2018;18(1):597.
  • Liu GM, Zeng HD, Zhang CY, et al. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int. 2019;19(1):138.
  • Wang F, Dufner-Beattie J, Kim BE, et al. Zinc-stimulated endocytosis controls activity of the mouse ZIP1 and ZIP3 zinc uptake transporters. J Biol Chem. 2004;279(23):24631–24639.
  • Bhutia YD, Babu E, Ramachandran S, et al. SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms. Biochem J. 2016;473(9):1113–1124.
  • Huang L, Kirschke CP, Zhang Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 2006;6(1):10.
  • Gumulec J, Masarik M, Krizkova S, et al. Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma. Curr Med Chem. 2011;18(33):5041–5051.
  • Barresi V, Valenti G, Spampinato G, et al. Transcriptome analysis reveals an altered expression profile of zinc transporters in colorectal cancer. J Cell Biochem. 2018;119(12):9707–9719.
  • Mei J, Hu K, Peng X, et al. Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma. Medicine (Baltimore). 2019;98(30):e16624.
  • Heiliger E, Osmanagic A, Haase H, et al. N-Cadherin-mediated cell adhesion is regulated by extracellular Zn(2+). Metallomics. 2015;7(2):355–362.
  • Mammadova-Bach E, Braun A. Zinc homeostasis in platelet-related diseases. Int J Mol Sci. 2019;20(21):21.
  • Baltaci AK, Yuce K. Zinc transporter proteins. Neurochem Res. 2018;43(3):517–530.
  • Golovine K, Makhov P, Uzzo RG, et al. Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo. Clin Cancer Res. 2008;14(17):5376–5384.
  • Desouki MM, Geradts J, Milon B, et al. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer. 2007;6(1):37.
  • Franklin RB, Zou J, Costello LC. The cytotoxic role of RREB1, ZIP3 zinc transporter, and zinc in human pancreatic adenocarcinoma. Cancer Biol Ther. 2014;15(10):1431–1437.
  • Jin H, Liu P, Wu Y, et al. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer. Cancer Sci. 2018;109(9):2946–2956.
  • Franklin RB, Feng P, Milon B, et al. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005;4(1):32.
  • Costello LC, Franklin RB, Zou J, et al. Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model. Cancer Biol Ther. 2011;12(12):1078–1084.
  • Golovine K, Uzzo RG, Makhov P, et al. Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway. Prostate. 2008;68(13):1443–1449.
  • Ding B, Lou W, Xu L, et al. Analysis the prognostic values of solute carrier (SLC) family 39 genes in gastric cancer. Am J Transl Res. 2019;11(1):486–498.
  • Trevisani F, Garuti F, Neri A. Alpha-fetoprotein for diagnosis, prognosis, and transplant selection. Semin Liver Dis. 2019;39(2):163–177.
  • Li B, Liu A, Wen Y, et al. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data. J Clin Lab Anal. 2021;35(9):e23932.
  • Tamai Y, Iwasa M, Eguchi A, et al. Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma. PLoS One. 2020;15(8):e0237370.
  • Kambe T, Geiser J, Lahner B, et al. Slc39a1 to 3 (subfamily II) Zip genes in mice have unique cell-specific functions during adaptation to zinc deficiency. Am J Physiol Regul Integr Comp Physiol. 2008;294(5):R1474–81.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.